• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Adjustable intragastric balloons are an effective and well-tolerated weight loss intervention

byJessie WillisandTeddy Guo
December 8, 2021
in Chronic Disease, Gastroenterology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A significantly greater reduction in total body weight was seen in the adjustable intragastric balloon group compared to the control group.

2. The intragastric balloon was removed early in 17% of patients due to intolerance.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Since the turn of the century, over 300 million adults globally are obese, leading the World Health Organization (WHO) to announce an “obesity epidemic.” Weight loss strategies are a controversial topic with varying success rates and patient compliance. A new minimally invasive intervention which follows a similar mechanism of the gastric bypass is a space-occupying intragastric balloon (IGB). This randomized-control trial tested the effectiveness of an adjustable silicone IGB (aIGB) for weight loss in adults with obesity. All patients enrolled in the study received dietary and exercise counselling. The study found that the aIGB group had a significantly greater percentage of total body weight loss compared to the counselling-only (control) group. Weight loss was also maintained in the majority of patients for six months after the aIGB device was removed. The aIGB was also well tolerated, with only 4% of individuals having serious adverse events. This study may have limited generalizability as the majority of patients were female. However, as the first randomized control trial of an IGB device, this study provides promising results for a minimally invasive medical device for weight loss.

Click to read the study in the Lancet

Click to read an accompanying editorial in the Lancet

Relevant Reading: Efficacy of commercial weight-loss programs: an updated systematic review

RELATED REPORTS

Spirituality may help patients with weight management after bariatric surgery

The 2 Minute Medicine Podcast Episode 11

Wellness Check: Spirituality

In-Depth [randomized controlled trial]: This randomized control trial enrolled patients aged 22-65 years of age with obesity (BMI ≥30) and a history of unsuccessful non-surgical weight loss attempts (n=288). Participants were randomized 2:1 to receive an adjustable intragastric balloon (aIGB) plus dietary and exercise counselling or counselling alone for a duration of 32 weeks. Age, sex, and initial weight distribution were similar between the two groups. Lifestyle modifications in both groups included a 1000-1200 kcal/day diet plus exercise plans. aIGB volumes varied from 400 mL to 550 mL initially based on height and could be increased or decreased based on patient needs. For patients in the intervention group, the aIGB was removed after 8 months and weight loss maintenance was assessed 6-months later. The primary outcome was weight loss as a percentage of total body weight.

In the intention-to-treat analysis, the aIGB group had a 15% total body weight loss compared with 3.3% in the control group (p<0.0001). The pre-defined superiority margin of 4.5% was exceeded (11.7%). In the 6-month post-removal follow-up, 74% of patients in the aIGB group maintained their pre-specified endpoint goal. There were 7 (4%) related adverse events in the aIGB group related to the device, but no deaths. No health issues, such as micronutrient deficiencies, were seen due to the device.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adjustable intragastric balloon (aIGB)body mass index (BMI)intragastric balloonobeseobesityoverweightweight lossweight management
Previous Post

Cataract surgery is associated with lower risk of developing dementia in older adults

Next Post

Wellness Check: Mental Health

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Chronic Disease

Spirituality may help patients with weight management after bariatric surgery

March 29, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 11

March 23, 2023
High incidence of cognitive impairment associated with colorectal cancer
Wellness

Wellness Check: Spirituality

March 23, 2023
Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Chronic Disease

Exercise and caloric restriction reduce visceral fat in overweight adults

March 14, 2023
Next Post
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse

Wellness Check: Mental Health

#VisualAbstract: Dual therapy with infliximab and IVIG in children with multi-system inflammatory syndrome

#VisualAbstract: Dual therapy with infliximab and IVIG in children with multi-system inflammatory syndrome

#VisualAbstract: Positron emission tomography effective at assessing early tumor response to induction chemotherapy in esophageal or esophagogastric junction cancers

#VisualAbstract: Positron emission tomography effective at assessing early tumor response to induction chemotherapy in esophageal or esophagogastric junction cancers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options